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ABSTRACT
Introduction: Asthma is now one of the most
common long-term conditions in the UK. It is therefore
important to develop a comprehensive appreciation of
the healthcare and societal costs in order to inform
decisions on care provision and planning. We plan to
build on our earlier estimates of national prevalence
and costs from asthma by filling the data gaps
previously identified in relation to healthcare and
broadening the field of enquiry to include societal
costs. This work will provide the first UK-wide
estimates of the costs of asthma. In the context of
asthma for the UK and its member countries (ie,
England, Northern Ireland, Scotland and Wales), we
seek to: (1) produce a detailed overview of estimates of
incidence, prevalence and healthcare utilisation; (2)
estimate health and societal costs; (3) identify any
remaining information gaps and explore the feasibility
of filling these and (4) provide insights into future
research that has the potential to inform changes in
policy leading to the provision of more cost-effective
care.
Methods and analysis: Secondary analyses of data
from national health surveys, primary care,
prescribing, emergency care, hospital, mortality and
administrative data sources will be undertaken to
estimate prevalence, healthcare utilisation and
outcomes from asthma. Data linkages and economic
modelling will be undertaken in an attempt to populate
data gaps and estimate costs. Separate prevalence and
cost estimates will be calculated for each of the UK-
member countries and these will then be aggregated to
generate UK-wide estimates.
Ethics and dissemination: Approvals have been
obtained from the NHS Scotland Information Services
Division’s Privacy Advisory Committee, the Secure
Anonymised Information Linkage Collaboration Review
System, the NHS South-East Scotland Research Ethics
Service and The University of Edinburgh’s Centre for
Population Health Sciences Research Ethics
Committee. We will produce a report for Asthma-UK,
submit papers to peer-reviewed journals and construct
an interactive map.
INTRODUCTION
Asthma is a common long-term condition
that is associated with considerable morbid-
ity, avoidable mortality and substantial costs
Strengths and limitations of this study
▪ This is so far the first study to estimate the
UK-wide and country-specific burden and cost of
asthma using available stand-alone and linked
routine data.
▪ This study will form the basis for creating the
UK Asthma Observatory for timely monitoring of
the burden of asthma.
▪ On the basis of our scoping search for data
sources, several of the data sets may be available
only at the aggregate, but not individual level,
example, Quality and Outcomes Framework data.
▪ Our scoping data search also indicates that not
all outcome measures have data available across
the different nations in the UK.
▪ Finally, all potential data gaps will be identified
and we will recommend ways of overcoming
these for future research work.
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to the National Health Service (NHS) and society.1 2
Our previous work on the epidemiology and burden of
allergy in the UK, driven mainly by asthma, has provided
important insights into asthma epidemiology and
resource utilisation and also demonstrated that the UK
ranks among the countries with the highest prevalence
in the world with a spend in excess of £1 billion in
direct healthcare expenditure in England and Wales and
an excess of £130 million in Scotland for asthma/
allergy.1–4 A recent systematic review investigating the
economic burden of asthma found that the costs asso-
ciated with asthma are increasing globally.5
There were, however, some important shortcomings in
our previous work.1–4 These include the fact that the
analyses undertaken related to England and Wales or
Scotland only, rather than the whole of the UK.
Furthermore, some healthcare data were not studied in
the previous works, for example, outpatient and accident
and emergency department (A&E) utilisation and their
associated costs. Moreover, estimates of the previous
works are now several years out of date.2 3 There is
therefore a need for a more comprehensive, contempor-
aneous picture of asthma epidemiology, healthcare util-
isation, outcomes and costs for the whole of the UK.
In this study, we seek to describe the epidemiology,
healthcare utilisation and costs of asthma for the UK as
a whole and its member countries by analysing second-
ary data available from national surveys and routine
administrative data sources across England, Northern
Ireland, Scotland and Wales. More speciﬁcally, we will
estimate for the UK as a whole and its member countries
for asthma the:
1. Incidence and prevalence.
2. Healthcare utilisation, including general practitioner
(GP) and nurse consultations, prescriptions,
out-of-hours calls, attendances at A&E services, ambu-
lance services, outpatient consultation, day case and
inpatient care and intensive care unit (ICU) provided
by the NHS and care provided at the patient’s home.
3. Healthcare costs due to (2) above.
4. Societal costs of asthma, including (3) above, and the
wider costs to society due to school absenteeism,
work absenteeism, disability living allowance (DLA),
care-at-home and mortality.
5. Where available, we will describe how each of these
estimates varies by age, gender, socioeconomic status
(SES) and ethnicity and over time.
METHODS
Ethical considerations and permissions
Since some patient-level data are to be used in Scotland
and Wales, approval was obtained from the Information
Services Division–NHS Scotland’s Privacy Advisory
Committee and the Secure Anonymised Information
Linkage (SAIL) Collaboration Review System, respect-
ively (see online supplementary appendices 1a, 1b.). For
the anonymised, aggregated data in Scotland, the NHS
South-East Scotland Research Ethics Service conﬁrmed
that ethical review was not required (see online supple-
mentary appendix 1c). For the entire work, on behalf of
all the participating Universities, we have processed this
application through The University of Edinburgh’s
Centre for Population Health Sciences Research Ethics
Committee; this self-assessment revealed that no further
ethical permissions were required.
Study period
We will describe the incidence and prevalence of asthma
and healthcare utilisation during the period 2001 and
2012, which will be presented by ﬁnancial years (ie,
April to March of the next year). Cost estimates of
asthma will be presented only for 2011–2012, since the
aim here is to estimate the latest costs of asthma for the
latest ﬁnancial year.
Study populations
The study population for each of the study outcomes
will be derived from the population of the respective
data set. Asthma will be deﬁned according to the diag-
nostic deﬁnition available in the respective data set. The
denominator in each data set will be based on the total
sample of people in the data set or the total population
in cases where the data set covers the entire population.
Assessment and definition of asthma
With respect to each data set, patients with asthma will
be deﬁned as follow:
1. being diagnosed with asthma in primary care based on
relevant Read codes (see online supplementary appen-
dices 2 and 3) or the International Classiﬁcation of
Disease (ICD) revision-9 code 493;6
2. respondents in health surveys who marked ‘yes’ for
doctor-diagnosed asthma or have reported having
symptoms suggestive of asthma;
3. dispensed asthma prescriptions prescribed by their
GP for asthma, where prescriptions are coded using
British National Formulary (BNF) codes (see online
supplementary appendix 4);7
4. used the NHS outpatient clinic or out-of-hours
service or ambulance service or A&E for asthma;
5. had a primary diagnosis of asthma with Read codes
(see online supplementary appendix 3) or the
ICD-10 code of J45 for asthma or J46 for status asth-
maticus,8 at discharge from hospital, at admission to
the ICU and on registration of death;
6. claimed DLA for asthma.9
Outcome measures
Incidence
Our primary aim is to measure healthcare utilisation;
therefore, our primary focus is to estimate asthma inci-
dent spells that have generated a contact with primary
care (see description for England below); second, where
possible, we will also estimate the incidence of ﬁrst
occurrence of asthma (incident cases; see description
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for Scotland and Wales below). However, considering
that an asthma episode may present in secondary care
and that most UK primary and secondary care data are
not linked, it will be challenging to identify with cer-
tainty if an asthma episode presenting in secondary care
represents the ﬁrst occurrence of the asthma case.
In England, the weekly incidence of asthma will be
estimated by averaging new weekly episodes recorded by
the Weekly Returns Service (WRS) of the Royal College of
General Practitioners.10 WRS receives notiﬁcations of
weekly episodes and numbers of consultations for
asthma using ICD-9 code 493 from about 90 GP prac-
tices covering over 800 000 people in England. WRS is
available by age groups and gender for each quarter and
year.
We could not identify any GP database in Northern
Ireland that could be used to estimate annual onset of
asthma by new GP consultation within the available
budget for this work.
In Scotland, Practice Team Information (PTI), a GP data-
base comprising a sample of 60 general practices repre-
senting about 6% of Scottish general practices and
around 6% of the Scottish patient population, will be
used to measure the onset of asthma resulting in new
GP consultation.11 PTI data include GP and nurse con-
sultations and diagnoses using Read codes, along with
demographics (see online supplementary appendix 2).
PTI was established in 2003–2004. We will use the year
2003–2004 as the starting point of follow-up for 5 years
and deﬁne onset of asthma by new GP consultation in
patients who were consistently in PTI since 2003–2004
and did not consult their GP for asthma for those
5 years, but consulted their GP for asthma after 2008–
2009. This assumes that patients who consulted their GP
for asthma before 2003 would come to see their GP at
least once in those 5 years.
In Wales, onset of asthma resulting in new GP consult-
ation will be estimated from the SAIL databank, which
currently collects data from 42% of the GP practices in
Wales.12 There are data on demographics and diagnoses
based on Read codes. Only patients who had not dereg-
istered from the participating GP practices and did not
consult a GP for asthma between 1996–1997 and 2000–
2001 will be taken into account.
Prevalence
We will estimate the annual and lifetime prevalence of
asthma,13 based on (a) national health surveys for the:
(i) patient’s report of symptoms indicative of asthma
(usually wheezing); (ii) patient’s report of doctor-
diagnosed asthma and (iii) patient’s report of doctor-
diagnosed asthma and doctor-treated asthma; and (b)
primary care for GP-diagnosed asthma and GP-treated
asthma.
We also aim to estimate the prevalence of asthma that
is likely to be allergic in origin, on the basis of the
patient having anaphylaxis, conjunctivitis, eczema, food
allergy, allergic rhinitis and urticaria (see online
supplementary appendix 5). Since up to 15% of patients
with chronic obstructive pulmonary disease (COPD)
may also have asthma, we will also estimate the preva-
lence of COPD in those with asthma aged 40 years and
above (see online supplementary appendix 6).14 Since
smoking is the key risk factor for COPD, past and
current smoking status will be queried (see online sup-
plementary appendix 7).
The health surveys to be used are the: Health Survey
for England (HSE) of 2001, 2004 and 2010; Northern
Ireland Health and Social Wellbeing Survey and the
Northern Ireland Health Survey of 2001, 2005/2006,
2010/2011 and 2011/2012; Scottish Health Survey
(SHeS) of 2003, 2008 and 2010; and the Welsh Health
Survey (WHS) of 2003, 2007, 2008, 2010 and 2011.
These surveys are of randomly selected samples of
people broadly representative of the respective general
population. They involve the collection of information
on health and utilisation of health services. Survey data
will be obtained from the UK Data Service.15
The prevalence estimates from the GP databases will
come from WRS in England, PTI in Scotland, SAIL in
Wales and the Quality and Outcomes Framework (QOF)
database across the four countries. QOF data are avail-
able from 2004. QOF is a fundamental part of the UK
General Medical Services contract, whereby general
practices are rewarded by incentives for providing
quality care to their patients.15 16 QOF data are,
however, aggregated numbers; hence, breakdown by age
and gender is impossible.
Healthcare utilisation in primary care
GP and nurse consultations
For estimating GP and nurse consultations for asthma,
WRS and HSE will be used for England, PTI and SHeS
for Scotland and SAIL-GP for Wales. We have not been
able to identify any suitable data source for Northern
Ireland.
Prescriptions
Some treatments commonly used for asthma (see online
supplementary appendix 4) may be used for the man-
agement of other disorders. Therefore, in order to
establish the usage of these medications for asthma, in
Scotland, patient records from Prescribing Information
System (PIS; available from 2009–2010) will be linked to
SHeS respondents who had mentioned having doctor-
diagnosed asthma.
For Wales, diagnosis and prescribing data will be
queried using the SAIL-GP database. PIS information is
on prescriptions dispensed, whereas SAIL-GP data are
for prescriptions written by GPs, but which may not
always have been dispensed. Dispensing is reported on a
monthly basis for Wales by drug and GP practices. These
totals can be reconciled against the prescribing by prac-
tice in the SAIL data to establish the proportions pre-
scribed and not dispensed and to help with the costing
estimates.
Mukherjee M, et al. BMJ Open 2014;4:e006647. doi:10.1136/bmjopen-2014-006647 3
Open Access
group.bmj.com on November 24, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
Although patient-level prescribing data are available in
Northern Ireland, diagnosis information is not available;
we will therefore not be in a position to conclusively
ascertain if treatments have been used for asthma or for
other indications.
In addition to the above data sources, data on commu-
nity prescriptions in each of the four countries will be
presented detailing numbers of items and costs by BNF
category available from Prescription Cost Analysis.17
Out-of-hours
Data on out-of-hours GP attendance will be obtained from
relevant NHS entities, where available. In England,
although an out-of-hours surveillance team exists, a break-
down by asthma is not available. We have not been able to
identify any comparable service in Northern Ireland.
Information on calls to out-of-hours using NHS-24, the
national telephone triage and advice service for Scotland,
is available from 2008 onwards.18 All out-of-hours calls
triaged by a nurse using asthma-speciﬁc algorithm to
support decision-making will be selected. The out-of-hours
data in Wales are inconsistently collected across areas and
hence will not be used.
Healthcare utilisation in secondary care
Outpatient clinics
Routine data on attendances in NHS outpatient clinics
are available across the four nations; these data are,
however, captured under the broader heading of
‘respiratory’ consultations, and it is therefore not pos-
sible to estimate the proportions of these consultations
that are for asthma. This will be noted as a major data
gap. In an attempt to ﬁll this gap, we will use HSE 2001
for England and SHeS for Scotland from the respective
questions: “How many times were you treated by (type of
medical professional) for your asthma/wheezing/whist-
ling in the last 12 months?” and “How many times were
you treated by a consultant/specialist or other doctor at
hospital outpatients for your (asthma/wheezing or whist-
ling) in the last 12 months?”.19–22 For Wales, estimates
will be obtained from the SAIL-Outpatient Database
from which asthma patients’ GP referral and atten-
dances to outpatient clinics for asthma will be extracted.
Ambulance service
Usage of the ambulance service due to asthma cannot
reliably be estimated from the aggregated routinely col-
lected data available in England, Northern Ireland and
Wales; this will therefore be identiﬁed as a data gap. For
England, a question from HSE 2010 will be used: “Have
(Has) you (name) had an asthma attack at school which
has involved any of these situations?”…“An ambulance
had to be called”.23 For Scotland, asthma data from the
Scottish Ambulance Service, which uses the record
“Emergency call-asthma selected”, will be used from
2008–2009 onwards.24
A&E services
In England and Northern Ireland, there are no accurate
published data on A&E attendances for asthma. For
England, a question in HSE 2001 “How many times were
you treated by (type of medical professional) for your
asthma/wheezing/whistling in the last 12 months?” will
be used.19 In Scotland, the A&E data mart will be used
for sites which report patient-level information from
their A&E departments since 2010–2011.25 If the
‘disease code’ includes the ICD-10 codes above or
‘R062’ (family history of asthma) or if the ‘presenting
complaint text’ or ‘diagnosis text’ referred to any of the
terms asthma, wheezing, low saturation, chest tightness
or shortness of breath, then those cases will be selected.
In Wales, the SAIL Emergency Department Data-set,
which contains data since 2009, will be used.26
Inpatient and day cases in hospitals
We will query the Hospital Episode Statistics for
England,27 the Department of Health, Social Service
and Public Safety in Northern Ireland,27 the General/
Acute Inpatient and Day Case data set for Scotland and
the SAIL Patient Episode Database for Wales,28 29 for a
primary diagnosis of asthma with ICD-10 codes to iden-
tify all asthma episodes. Hospital-based prescribing is
not, however, included in these data sets.
Intensive care units
Paediatric ICUs (PICU): The Paediatric Intensive Care
Audit Network is a national audit which collects data on
all critically ill children admitted to PICUs across the
UK.30 It has data from PICUs from England and Wales
from 2002, from Northern Ireland from 2008 and from
Scotland from 2007, recorded in Read V.3 (see online
supplementary appendix 3).18
Adult ICUs: For England, Northern Ireland and Wales,
we will use Intensive Care National Audit & Research
Centre data, which have been collected since 1996.31
For Scotland, the Scottish Intensive Care Society Audit
Group data will be queried, which uses ICD-10 codes.32
Wider societal costs
Since there may be people with asthma who might not
be using health services, but may be sustaining social
and economic costs, we will investigate absenteeism,
care-at-home, contacts made with the Department of
Work and Pensions (DWP), the government agency pro-
viding national beneﬁts and lost productivity due to
early death.
School absenteeism
For England, HSE 2010 with the question “Over the last
12 months, how many days has your (name) asthma/
wheezing/whistling in (your/his/her) chest caused
(you/him/her) to be absent from school?” will be used
among asthma respondents. We could not identify any
suitable data source to investigate school absenteeism in
Northern Ireland, Scotland or Wales.
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Work absenteeism
For England, the HSE 2010 question “Over the last
12 months, how many days has your wheezing/whistling
in your chest, shortness of breath or difﬁculty in breath-
ing caused you to be absent from work?” will be used
among asthma respondents. Sickness-leave data from the
Northern Ireland civil service from the Department of
Finance and Personnel will be used on workdays lost
due to asthma.33 We were unable to ﬁnd any suitable
data sources for Scotland and Wales. Workdays lost due
to occupational asthma will be obtained from 2005
onwards from The Health and Occupation Research
Network, which collates data from a research network of
over 2000 specialist physicians and specially trained GPs
throughout the UK.34
Care-at-home
We have been unable to identify any suitable data to esti-
mate costs of care-at-home for asthma from England,
Scotland and Northern Ireland. The only data we have
identiﬁed come from a recent project undertaken by
the Swansea Centre for Health Economics in collabor-
ation with the Swansea Social Services available in SAIL,
detailing home-care service packages and costs to
people aged 50 years and above and living within the
city and county of the Swansea council area.35
Disability living allowance
There are aggregated data available from DWP on a
number of people receiving DLA, total DLA amount
and expenditure on people receiving DLA due to
asthma for England, Scotland and Wales for 2011–2012.9
For Northern Ireland, there are data available from the
Department for Social Development on the number of
people with asthma receiving DLA and total amount by
age group, gender and SES from 2008.36
Premature retirement
So far, no data source has been identiﬁed.
Mortality
Mortality data with a primary or secondary cause of
asthma from death certiﬁcates, coded using ICD-10, are
available from the Ofﬁce of National Statistics for England
and Wales,37 the Northern Ireland Statistics and the
Research Agency and General Register Ofﬁce for
Scotland.38 39
Covariates
We aim to present the estimates of incidence, prevalence
and healthcare utilisation by age, gender, SES and
ethnicity, where data for these covariates are available,
provided risks of individuals’ identity being disclosed is
not compromised. For cost estimates, the covariates will
be limited to the primary covariates of age and gender.
For age, estimates will be given for children (aged under
15 years) and adults (15 years and above). In addition, to
facilitate comparisons of prevalence estimates with results
from the International Study of Asthma and Allergies in
Childhood, we will also present estimates of prevalence by
age groups 6–7 and 13–14 years.1
Gender will be classiﬁed as male and female.
SES will be categorised into quintiles based on the:
English Index of Multiple Deprivation in England40;
Northern Ireland Multiple Deprivation Measure in
Northern Ireland41; Scottish Index of Multiple Deprivation
in Scotland42; and Welsh Index of Multiple Deprivation in
Wales,43 as are available in the data sets.
Where available, ethnicity will be classiﬁed as per the
2011 censuses in the respective countries (see online
supplementary appendix 8).44–47
Analysis
Incidence, prevalence, time trends and healthcare utilisation
The incidence of asthma for a speciﬁc year from the
respective national GP data sets will be calculated as the
number of new patients diagnosed with asthma in that
year divided by the total number of patients registered
with the participating GP practices at the beginning of that
year. Lifetime prevalence of asthma for a speciﬁc year
from respective national health surveys will be calculated
as the number of respondents who reported ever having
had asthma divided by the total number of respondents in
that year. The annual prevalence of asthma from respect-
ive national data sets will be calculated as the number of
patients who reported/were diagnosed to have asthma
divided by the total number of participants in the respect-
ive data set for that speciﬁc year. The incidence, preva-
lence and healthcare utilisation estimates will be
multiplied by 1000 to give estimates per 1000 of the popu-
lation. These will be presented by ﬁnancial years and,
where possible, by age groups, gender, SES and ethnicity.
The European standard population V.2013 will be used as
the reference population to age standardise the rates for
comparison across countries.48 Crude rates will be pro-
vided where age breakdowns are not available. All esti-
mates will be accompanied by their respective 95% CI,
where appropriate based on the Poisson approximation.49
Trends over time will be presented based on years of data
availability.
Health and societal care costs of asthma
Healthcare costs will be estimated from an NHS perspec-
tive based on the healthcare utilisation detailed above.
Where a given data set does not inherently include a
cost estimate, standard UK weights will be applied. The
majority of primary care price weights will be taken from
the Personal and Social Services Research Unit annual
unit costs.50 Inpatient care costs will be based on
Healthcare Resource Grouping codes version-4 in the
Department of Health reference costs or the Scottish
National Tariff for Scotland.51 52 Costs of prescribing will
be based on net ingredient costs from the prescribing
databases of the respective countries. Societal costs will
be estimated from a wider societal perspective including
NHS costs as above, DLA and lost work productivity
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estimated using a Human Capital approach.53 The latter
estimate will be undertaken by applying the national
average wage rates by age group and gender to estimate
lost productivity due to absenteeism and death (up to a
conservatively assumed retirement age of 65). All costs
will be estimated from a base year of 2011/2012 applying
appropriate inﬂation indices where required.
Addressing data gaps
Data gaps can take three forms: (1) within the country
—where no single data set in a given country holds sufﬁ-
cient variables to provide an estimate, but linkages
between data sets may overcome this; (2) between coun-
tries—where data on the variable of interest (after allow-
ing for linkages) are available in one member country,
but not in another or (3) across the country—where no
data (after allowing for linkages) from any member
country are found for the variable of interest.
Appropriate linkages will be explored for Type 1 data
gaps. Type 2 will be addressed by mapping estimates of a
given variable from one country where data are available
to another, based on the age group and gender. Where
this is not possible or where a gap is of Type 3, estimate
from the wider literature may be used. As the time
frame for the study does not permit a full systematic
review to identify such parameters, this may be based on
a simple literature search or parameters found in the
Health Economic Evaluation Database,54 with the most
appropriate parameter estimate selected based on
expert judgement from the team.
Economic modelling
An economic model of the cost of asthma in the UK
and its member countries will be built in Microsoft
Excel 2010. This will be used to:
1. Apply the mapping techniques and synthesis of data
with wider literature and price weights,
2. Sum up the cost estimates into the required group-
ings (eg, NHS costs, wider societal costs each by the
age and gender groupings described above), and esti-
mate 95% CI around the joint distributions of each
total cost estimate with each cost element and total
presented as cost per 1000 population as well as an
absolute ﬁgure. In order to estimate CI around the
cost totals, the model will apply probability distribu-
tions based on the observed means and appropriate
measures of uncertainty (such as SEs or SDs) for
parameters of interest. The CI will be estimated by
taking bootstrapped samples from the distributions
applied to each parameter simultaneously and
running the model based on this set of sampled par-
ameter estimates, thus capturing their joint distribu-
tion within the bootstrapped sample. The required
95% CI will then be estimated using the percentile
method based on these samples.55
UK-wide estimates can be provided for the outcomes
by pooled data analysis only if there is homogeneity.
However, if among the individual countries there is
excessive heterogeneity, then it will not be appropriate
to pool national estimates.
Project timeline and current status
This project started in October 2013 and will end in
December 2014. Currently, the teams are in the process
of acquiring and analysing data.
Implications
The current project will, for the ﬁrst time, generate reli-
able estimates of the incidence, prevalence, trends,
healthcare utilisation and health and social care costs of
asthma for the UK as a whole and for its individual
member nations. The conclusion of this project will
mark an important milestone in comprehensively appre-
ciating the overall burden posed by asthma in the
country. The project ﬁndings will serve as an important
resource for policymakers in informing policy delibera-
tions on effective service planning and provision for
people with asthma.
This project should provide a summary of the key avail-
able data sources for asthma epidemiology, health and
social services use and costs in the UK and its member
countries. In this vein, identiﬁcation of data gaps will assist
deliberations on how to plug these gaps in order to
develop a comprehensive picture of people living with
long-term conditions. Furthermore, we will recommend
possible ways of ﬁlling these gaps. Moreover, we are in the
longer term in the process of creating a UK Asthma
Observatory, which will represent a signiﬁcant milestone
in the ﬁeld of asthma research in the UK through which
real-time trends of asthma can be monitored, and this
work should serve as an important foundation in this
respect. Ultimately, this should serve as a motivation for
setting up such observatories in other European countries.
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